EUROLAB
21-cfr-part-211165-testing-and-release-for-distribution
Sterility and Microbial Limit Testing 21 CFR Part 211.113 Control of Microbiological Contamination21 CFR Part 211.167 Special Testing RequirementsAOAC 2003.01 Testing for Escherichia coli and ColiformsAOAC 2003.07 Microbial Enumeration for Nutritional SupplementsAOAC 966.23 Microbial Limits in CosmeticsEN 556-1 Requirements for Medical Devices Labeled ‘Sterile’EN 556-2 Requirements for Sterile Barrier SystemsEN 868-1 Packaging Materials for Terminally Sterilized Medical DevicesEN 868-2 Sterilization WrapsEN 868-3 Paper for Use in SterilizationEN 868-4 Paper Bags for Steam SterilizationEN 868-5 Heat Sealable PouchesEN 868-6 Paper for Low Temperature SterilizationEN 868-7 Nonwoven WrapsEN 868-8 Reusable Textiles for Sterile Barrier SystemsEN ISO 11607-1 Packaging for Terminally Sterilized Medical Devices – RequirementsEN ISO 11607-2 Packaging Validation RequirementsEP 2.6.1 Sterility Testing of Finished Dosage FormsEP 2.6.12 Microbiological Examination of Non-Sterile Products: Microbial Enumeration TestsEP 2.6.13 Microbiological Examination of Non-Sterile Products: Test for Specified MicroorganismsFDA BAM Chapter 10 Listeria monocytogenes DetectionFDA BAM Chapter 14 Bacillus cereus TestingFDA BAM Chapter 18 Microbial Limits for CosmeticsFDA BAM Chapter 3 Aerobic Plate Count for Food and SupplementsFDA BAM Chapter 4 Enumeration of Yeast and MoldFDA BAM Chapter 5 Coliforms and E. coli DetectionFDA BAM Chapter 7 Staphylococcus aureus DetectionFDA BAM Chapter 8 Salmonella DetectionICH Q10 Pharmaceutical Quality SystemICH Q6A Specifications for New Drug SubstancesICH Q6B Specifications for Biotechnological ProductsICH Q7 GMP for Active Pharmaceutical IngredientsICH Q9 Quality Risk ManagementISO 11135 Validation of Sterilization by Ethylene OxideISO 11137-1 Sterilization of Healthcare Products – RadiationISO 11137-2 Establishing the Sterilization DoseISO 11137-3 Guidance on Dosimetric Aspects for Radiation SterilizationISO 11138-1 Biological Indicators – General RequirementsISO 11138-2 Biological Indicators for Ethylene Oxide Sterilization ProcessesISO 11138-3 Biological Indicators for Steam Sterilization ProcessesISO 11138-4 Biological Indicators for Dry Heat Sterilization ProcessesISO 11138-5 Biological Indicators for Low-Temperature Steam and FormaldehydeISO 11737-1 Bioburden Determination on Medical DevicesISO 11737-2 Tests of Sterility Assurance for Medical DevicesISO 13408-1 Aseptic Processing of Healthcare ProductsISO 13408-2 Sterilizing FiltrationISO 13408-3 Lyophilization for Aseptic ProcessingISO 13408-4 Clean-in-Place for Aseptic ProcessingISO 13408-5 Sterilization-in-PlaceISO 13408-6 Isolator Systems for Aseptic ProcessingISO 13408-7 Aseptic ConnectionsISO 14160 Sterilization of Medical Devices Using Liquid Chemical SterilantsISO 14644-1 Cleanroom Classification by Particle CountISO 14644-10 Classification of Surface Chemical CleanlinessISO 14644-2 Cleanroom Monitoring to Provide Evidence of CleanlinessISO 14644-3 Test Methods for CleanroomsISO 14644-4 Design, Construction and Start-Up of CleanroomsISO 14644-5 Operations in CleanroomsISO 14644-6 VocabularyISO 14644-7 Separative Devices (Clean Air Hoods, Gloveboxes, etc.)ISO 14644-8 Airborne Molecular ContaminationISO 14644-9 Classification of Surface Particle CleanlinessISO 14698-1 Biocontamination Control in Cleanrooms and Controlled EnvironmentsISO 14698-2 Evaluation Methods for Biocontamination ControlISO 14937 General Requirements for Sterilization ProcessesISO 15883-1 Washer-Disinfectors for Medical DevicesISO 15883-2 Washer-Disinfectors for Surgical InstrumentsISO 15883-3 Washer-Disinfectors for Human Waste ContainersISO 15883-4 Washer-Disinfectors for Thermolabile EndoscopesISO 15883-5 Test Soils and Methods for Washer-DisinfectorsISO 15883-6 Washer-Disinfectors for Baby Bottles and UtensilsISO 17665-1 Moist Heat Sterilization of Healthcare ProductsISO 17665-2 Guidance on Moist Heat Sterilization ValidationISO 18362 Manufacture of Sterile Medicinal ProductsJP 4.05 Sterility Testing for Injectable ProductsJP 4.06 Microbial Limit Tests for Pharmaceutical ProductsPDA TR 1 Sterility Testing GuidelinePDA TR 27 Pharmaceutical Package IntegrityPDA TR 28 Process Simulation TestingPDA TR 36 Isolator Systems for Sterility AssurancePDA TR 69 Bioburden and Cleanroom Microbial ControlPDA TR 70 Sterilization of Drug Products by Moist HeatPh. Eur. 2.6.30 Bacterial Endotoxins – LAL TestPh. Eur. 5.1.10 Guidelines for Viral Safety of Biotechnological ProductsPh. Eur. 5.1.2 Biological Indicators for Sterilization ProcessesPh. Eur. 5.1.4 Cleanroom and Isolator Environmental MonitoringPh. Eur. 5.1.6 Container Closure Integrity for Sterile ProductsPh. Eur. 5.1.8 Microbiological Quality of Herbal PreparationsTGA TG-GMP Sterility Requirements for Medicinal ProductsUSP <1211> Sterilization and Sterility AssuranceUSP <1222> Terminally Sterilized Drug ProductsUSP <1229> Sterilization of Compendial ArticlesUSP <1231> Water for Pharmaceutical PurposesUSP <2021> Microbiological Testing of Nutritional and Dietary SupplementsUSP <2022> Microbiological Testing of Nonsterile Personal Care ProductsUSP <55> Biological Indicators – Resistance Performance TestsUSP <61.1> Microbial Limit Testing for CosmeticsUSP <61> Microbial Enumeration Test for Non-Sterile ProductsUSP <62> Test for Specified Microorganisms in Pharmaceutical ProductsUSP <71> Sterility Test for Parenteral Drug Products

21 CFR Part 211.165 Testing and Release for Distribution Laboratory Testing Service Provided by Eurolab

As a leading laboratory testing service provider, Eurolab understands the importance of adhering to stringent standards in ensuring the quality and safety of products. The 21 CFR Part 211.165 Testing and Release for Distribution is a critical regulatory requirement that ensures the safety and efficacy of pharmaceuticals and medical devices.

International and National Standards

The following international and national standards govern the 21 CFR Part 211.165 Testing and Release for Distribution testing:

  • ISO 13485:2016 (Medical Devices Quality Management Systems Requirements for Regulatory Purposes)

  • ASTM E2500-13 (Standard Guide for Selection of Criteria and Test Methods for Significance of Workmanship Defects in Materials and Products)

  • EN ISO 9001:2015 (Quality Management Systems Requirements)

  • TSE 13485:2009 (Medical Devices Quality Management System Requirements)

    • These standards outline the requirements for testing, documentation, and reporting to ensure compliance with regulatory agencies.

    Standard Development Organizations

    Standard development organizations (SDOs) play a crucial role in creating and updating standards. Some prominent SDOs include:

  • International Organization for Standardization (ISO): Develops and publishes international standards.

  • American Society for Testing and Materials (ASTM): Develops and publishes voluntary consensus standards for materials, products, systems, and services.

  • European Committee for Electrotechnical Standardization (CENELEC): Develops and publishes European standards for electrotechnical products.

    • Evolving Standards

    Standards evolve over time to reflect changing regulatory requirements, technological advancements, or industry best practices. SDOs regularly review and update standards to ensure they remain relevant and effective.

    Standard Numbers and Scope

    The following standard numbers and their scope are relevant to 21 CFR Part 211.165 Testing and Release for Distribution testing:

  • ISO 13485:2016: Applies to organizations involved in the design, development, production, installation, and delivery of medical devices.

  • ASTM E2500-13: Covers the selection of criteria and test methods for evaluating workmanship defects in materials and products.

  • EN ISO 9001:2015: Establishes requirements for a quality management system to ensure customer satisfaction, continuous improvement, and conformity to product requirements.

    • Industry-Specific Standard Compliance

    Different industries have specific standard compliance requirements. For example:

  • Medical Devices Industry: Complies with standards like ISO 13485:2016 and EN ISO 9001:2015.

  • Pharmaceutical Industry: Complies with standards like ASTM E2500-13.

    • Business and Technical Reasons for Testing

    Conducting 21 CFR Part 211.165 Testing and Release for Distribution testing is essential for several business and technical reasons:

  • Ensures Product Safety: Verifies that products meet regulatory requirements, ensuring customer safety.

  • Maintains Quality: Ensures that products conform to specified standards, enhancing quality.

  • Compliance with Regulations: Meets regulatory agency requirements, avoiding fines and penalties.

    • Consequences of Not Performing the Test

    Failure to conduct 21 CFR Part 211.165 Testing and Release for Distribution testing can result in:

  • Product Recall: Products may need to be recalled due to non-compliance.

  • Loss of Business Reputation: Non-compliance can damage a companys reputation, leading to loss of customer trust.

  • Regulatory Fines: Failure to comply with regulations can result in significant fines.

    • Industries and Sectors Requiring Testing

    The following industries and sectors require 21 CFR Part 211.165 Testing and Release for Distribution testing:

  • Pharmaceutical Industry

  • Medical Devices Industry

    • Risk Factors and Safety Implications

    Non-compliance to standards can lead to various risk factors, including:

  • Product Liability: Companies may be held liable for any harm caused by non-compliant products.

  • Reputational Damage: Non-compliance can damage a companys reputation.

    • Testing Equipment and Instruments

    The following equipment and instruments are used in 21 CFR Part 211.165 Testing and Release for Distribution testing:

  • High-Performance Liquid Chromatography (HPLC)

  • Gas Chromatography (GC)

  • Mass Spectrometry (MS)

    • Sample Preparation Procedures

    Sample preparation procedures include:

  • Extraction: The extraction process involves using solvents or other substances to extract analytes from the sample.

  • Cleanup: This step involves removing any impurities or contaminants that may interfere with the analysis.

    • Testing and Validation

    Eurolabs testing and validation processes ensure accuracy and reliability of results. Our team conducts regular quality control checks to guarantee compliance with regulatory standards.

    Data Analysis and Reporting

    Data analysis and reporting involve:

  • Statistical Analysis: This involves using statistical software to analyze data.

  • Reporting: Reports are generated based on the results obtained from testing, which is then used for documentation and regulatory purposes.

    • Test Results and Interpretation

    Eurolabs experienced team interprets test results accurately, providing detailed reports that meet client requirements.

    Document Control

    Document control involves maintaining accurate records of all laboratory data, including:

  • Raw Data: Raw data includes any original data collected during testing.

  • Processed Data: Processed data includes any data that has been altered or transformed for analysis.

    • Calibration and Maintenance

    Regular calibration and maintenance of equipment ensure accuracy and reliability of results.

    Training and Qualification

    Eurolabs team receives regular training to maintain their proficiency in laboratory procedures, ensuring they are up-to-date with the latest standards and regulations.

    Test Validation

    Eurolab conducts regular test validation to guarantee that our methods meet regulatory requirements and produce accurate results.

    Standard Operating Procedures (SOPs)

    Our SOPs ensure consistency and accuracy in testing. Our team follows established protocols for sampling, analysis, and reporting.

    Equipment Maintenance

    Regular maintenance of equipment ensures optimal performance and reduces the risk of errors.

    Documentation and Record-Keeping

    Accurate documentation and record-keeping are essential for maintaining compliance with regulatory requirements.

    Test Results and Interpretation

    Eurolabs experienced team interprets test results accurately, providing detailed reports that meet client requirements.

    Conclusion

    Eurolab is committed to ensuring the highest standards of quality and safety in laboratory testing. Our expertise and commitment to excellence guarantee accurate results that meet or exceed regulatory requirements.

    By understanding the importance of 21 CFR Part 211.165 Testing and Release for Distribution testing, you can ensure compliance with regulations and maintain a reputation as a trustworthy supplier.

    Eurolabs dedication to providing high-quality services ensures customer satisfaction and maintains our position as a leader in laboratory testing.

    Acknowledgement

    Thank you for taking the time to read this comprehensive guide on 21 CFR Part 211.165 Testing and Release for Distribution laboratory testing service provided by Eurolab.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers